ATE162224T1 - Crf bindungsproteine - Google Patents

Crf bindungsproteine

Info

Publication number
ATE162224T1
ATE162224T1 AT94901223T AT94901223T ATE162224T1 AT E162224 T1 ATE162224 T1 AT E162224T1 AT 94901223 T AT94901223 T AT 94901223T AT 94901223 T AT94901223 T AT 94901223T AT E162224 T1 ATE162224 T1 AT E162224T1
Authority
AT
Austria
Prior art keywords
crf
protein
proteins
antibodies
dna
Prior art date
Application number
AT94901223T
Other languages
English (en)
Inventor
Ellen Potter
Dominic P Behan
Wolfgang H Fischer
Elizabeth A Linton
Philip J Lowry
Wylie Walker Vale Jr
Original Assignee
Salk Inst For Biological Studi
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi, Univ Reading filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE162224T1 publication Critical patent/ATE162224T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94901223T 1992-10-26 1993-10-25 Crf bindungsproteine ATE162224T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96768392A 1992-10-26 1992-10-26
US08/097,828 US5464757A (en) 1991-01-15 1993-07-23 DNA encoding CRF binding protein

Publications (1)

Publication Number Publication Date
ATE162224T1 true ATE162224T1 (de) 1998-01-15

Family

ID=26793683

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94901223T ATE162224T1 (de) 1992-10-26 1993-10-25 Crf bindungsproteine

Country Status (6)

Country Link
US (2) US5464757A (de)
EP (1) EP0667916B1 (de)
AT (1) ATE162224T1 (de)
CA (1) CA2147875C (de)
DE (1) DE69316388T2 (de)
WO (1) WO1994010333A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK6893D0 (da) * 1993-01-21 1993-01-21 Novo Nordisk As Peptid
US5587462A (en) * 1993-11-08 1996-12-24 The Salk Institute For Biological Studies Brain-derived membrane-associated CRF binding proteins
CA2195197A1 (en) * 1994-07-15 1996-02-01 Neurocrine Biosciences, Inc. Corticotropin-releasing factor-binding-protein inhibitors and their use
WO1996002569A1 (en) * 1994-07-15 1996-02-01 Neurocrine Biosciences, Inc. Corticotropin-releasing factor-binding-protein inhibitors and their use
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
AU765512B2 (en) * 1998-07-24 2003-09-18 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Antagonists specific for the corticotropin-releasing factor receptor type 2 (CRFR2)
US20130344102A1 (en) * 2012-06-25 2013-12-26 Aimsco Limited Formulation
WO2018132768A1 (en) * 2017-01-13 2018-07-19 Sanna Pietro P Methods and compositions for treating hpa hyperactivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
ATE191502T1 (de) * 1991-01-15 2000-04-15 Salk Inst For Biological Studi Corticotropinauslösefaktor-bindendes protein

Also Published As

Publication number Publication date
US5464757A (en) 1995-11-07
DE69316388D1 (de) 1998-02-19
CA2147875C (en) 2002-04-02
EP0667916A1 (de) 1995-08-23
WO1994010333A1 (en) 1994-05-11
US5844080A (en) 1998-12-01
CA2147875A1 (en) 1994-05-11
DE69316388T2 (de) 1998-08-13
EP0667916B1 (de) 1998-01-14

Similar Documents

Publication Publication Date Title
Sobel et al. Non-random acetylation of histone H4 by a cytoplasmic histone acetyltransferase as determined by novel methodology
Gray et al. Aα and Bβ chains of fibrinogen stimulate proliferation of human fibroblasts
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
DE69309472D1 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
EP0653940A4 (de) Glialmitogene faktoren, ihre herstellung und verwendung.
Hopsu-Havu et al. Formation of bradykinin from kallidin-10 by aminopeptidase B
Summaria et al. Isolation and characterization of the affinity chromatography forms of human Glu-and Lys-plasminogens and plasmins.
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
WO1996006168A3 (en) Retinoblastoma protein-interacting zinc finger proteins
ES2103266T3 (es) Procedimiento de dna recombinante y celulas huesped.
AU669540B2 (en) Monoclonal antibody against protein C
ATE69108T1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
ATE208816T1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
ATE372384T1 (de) Protein-tyrosin-phosphatase ptp-s31
ATE162224T1 (de) Crf bindungsproteine
Swerdlow et al. Affinity of HMG17 for a mononucleosome is not influenced by the presence of ubiquitin-H2A semihistone but strongly depends on DNA fragment size
WO1994003611A3 (en) Ptp-d subfamily of protein tyrosine phosphatases
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
KR900003207A (ko) 트롬빈 결합성 물질 및 이의 제조방법
DE69132813D1 (de) Genetisches igfbp-5 rodierendes material
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE189700T1 (de) Genetisches igfbp-4 rodierendes material
DE69233155D1 (de) Insulinartigen wachstumsfaktor bindendes protein
NO992107L (no) FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties